Transforming The Business Of Clinical Trial Site Contracting: The Hybrid Model

Peg Tierney

In previous posts, I explored many of the challenges facing clinical trial enterprises and introduced three models for site contracting: Conservative, Progressive and Hybrid. So far, I’ve discussed the Conservative site contracting model and the Progressive site contracting model. For this third and final post, I’d like to highlight the Hybrid Model—which blends the Conservative and Progressive Models for site contracting.

From the largest global pharma companies to highly focused pharma and biotech startups, many sponsors see the value in the Hybrid Model. This approach enables a sponsor to retain more control over risk and quality than in the Progressive Model—while avoiding the long delays and high costs typically associated with the Conservative Model.